Moderna Inc
NASDAQ:MRNA
Moderna Inc
Change in Deffered Taxes
Moderna Inc
Change in Deffered Taxes Peer Comparison
Competitive Change in Deffered Taxes Analysis
Latest Figures & CAGR of Competitors
Company | Change in Deffered Taxes | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Moderna Inc
NASDAQ:MRNA
|
Change in Deffered Taxes
$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Deffered Taxes
-$3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Deffered Taxes
-$1.4B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-26%
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Deffered Taxes
-$1.6B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Deffered Taxes
-$581.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
-14%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Deffered Taxes
-$811.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
See Also
What is Moderna Inc's Change in Deffered Taxes?
Change in Deffered Taxes
1.1B
USD
Based on the financial report for Mar 31, 2024, Moderna Inc's Change in Deffered Taxes amounts to 1.1B USD.